RESUMO
Ex vivo islet cell culture prior to transplantation appears as an attractive alternative for treatment of type 1 diabetes. Previous results from our laboratory have demonstrated beneficial effects of human prolactin (rhPRL) treatment on human islet primary cultures. In order to probe into the molecular events involved in the intracellular action of rhPRL in these cells, we set out to identify proteins with altered expression levels upon rhPRL cell treatment, using two-dimensional (2D) gel electrophoresis and mass spectrometry (MS). An average of 300 different protein spots were detected, 14 of which were modified upon rhPRL treatment (p<0.01), of which 12 were successfully identified using MS and grouped according to their biological functions. In conclusion, our study provides, for the first time, information about proteins that could be critically involved in PRL's action on human pancreatic islets, and facilitate identification of new and specific targets involved in islet cell function and proliferation.
Assuntos
Proliferação de Células/efeitos dos fármacos , Regulação da Expressão Gênica/efeitos dos fármacos , Ilhotas Pancreáticas/metabolismo , Prolactina/farmacologia , Adulto , Eletroforese em Gel Bidimensional , Feminino , Humanos , Ilhotas Pancreáticas/citologia , Transplante das Ilhotas Pancreáticas , Masculino , Espectrometria de Massas , Pessoa de Meia-Idade , Proteínas Recombinantes de Fusão/farmacologia , Técnicas de Cultura de TecidosRESUMO
Diabetes mellitus is a widespread disease whose frequency increases constantly and is expected to reach alarming levels by the year 2025. Introduction of insulin therapy represented a major breakthrough; however, a very strict regimen is required to maintain blood glucose levels within the normal range and to prevent or postpone chronic complications associated with this disease. Frequent hyper- and hypoglycemia seriously affect the quality of life of these patients. Reversion of this situation can only be achieved through whole organ (pancreas) transplant or pancreatic islet transplant, the former being a high-risk surgical procedure, while the latter is a much simpler and may be accomplished in only 20-40 min. The advantages and perspectives of islet cell transplantation will be discussed, in the light of tissue engineering and gene therapy. Ongoing research carried out in our laboratory, aimed at developing clinical cell and molecular therapy protocols for diabetes will also be focused
Assuntos
Criança , Adolescente , Adulto , Humanos , Masculino , Feminino , Terapia Baseada em Transplante de Células e Tecidos , Diabetes Mellitus/cirurgia , Diabetes Mellitus/terapia , Transplante das Ilhotas Pancreáticas , Transplante de PâncreasRESUMO
In the 70's, pancreatic islet transplantation arose as an attractive alternative to restore normoglycemia; however, the scarcity of donors and difficulties with allotransplants, even under immunosuppressive treatment, greatly hampered the use of this alternative. Several materials and devices have been developed to circumvent the problem of islet rejection by the recipient, but, so far, none has proved to be totally effective. A major barrier to transpose is the highly organized islet architecture and its physical and chemical setting in the pancreatic parenchyma. In order to tackle this problem, we assembled a multidisciplinary team that has been working towards setting up the Human Pancreatic Islets Unit at the Chemistry Institute of the University of São Paulo, to collect and process pancreas from human donors, upon consent, in order to produce purified, viable and functional islets to be used in transplants. Collaboration with the private enterprise has allowed access to the latest developed biomaterials for islet encapsulation and immunoisolation. Reasoning that the natural islet microenvironment should be mimicked for optimum viability and function, we set out to isolate extracellular matrix components from human pancreas, not only for analytical purposes, but also to be used as supplementary components of encapsulating materials. A protocol was designed to routinely culture different pancreatic tissues (islets, parenchyma and ducts) in the presence of several pancreatic extracellular matrix components and peptide growth factors to enrich the beta cell population in vitro before transplantation into patients. In addition to representing a therapeutic promise, this initiative is an example of productive partnership between the medical and scientific sectors of the university and private enterprises.
Assuntos
Humanos , Engenharia Biomédica/métodos , Diabetes Mellitus/cirurgia , Transplante das Ilhotas Pancreáticas/métodos , Ilhotas Pancreáticas/fisiologia , Materiais Biocompatíveis , Cápsulas , Técnicas de Cultura/métodos , Diabetes Mellitus Tipo 1/cirurgia , Matriz Extracelular , Sobrevivência de Enxerto , Ilhotas Pancreáticas/imunologiaRESUMO
In the 70's, pancreatic islet transplantation arose as an attractive alternative to restore normoglycemia; however, the scarcity of donors and difficulties with allotransplants, even under immunosuppressive treatment, greatly hampered the use of this alternative. Several materials and devices have been developed to circumvent the problem of islet rejection by the recipient, but, so far, none has proved to be totally effective. A major barrier to transpose is the highly organized islet architecture and its physical and chemical setting in the pancreatic parenchyma. In order to tackle this problem, we assembled a multidisciplinary team that has been working towards setting up the Human Pancreatic Islets Unit at the Chemistry Institute of the University of São Paulo, to collect and process pancreas from human donors, upon consent, in order to produce purified, viable and functional islets to be used in transplants. Collaboration with the private enterprise has allowed access to the latest developed biomaterials for islet encapsulation and immunoisolation. Reasoning that the natural islet microenvironment should be mimicked for optimum viability and function, we set out to isolate extracellular matrix components from human pancreas, not only for analytical purposes, but also to be used as supplementary components of encapsulating materials. A protocol was designed to routinely culture different pancreatic tissues (islets, parenchyma and ducts) in the presence of several pancreatic extracellular matrix components and peptide growth factors to enrich the beta cell population in vitro before transplantation into patients. In addition to representing a therapeutic promise, this initiative is an example of productive partnership between the medical and scientific sectors of the university and private enterprises.
Assuntos
Engenharia Biomédica/métodos , Diabetes Mellitus/cirurgia , Transplante das Ilhotas Pancreáticas/métodos , Ilhotas Pancreáticas/fisiologia , Materiais Biocompatíveis , Cápsulas , Técnicas de Cultura/métodos , Diabetes Mellitus Tipo 1/cirurgia , Matriz Extracelular , Sobrevivência de Enxerto , Humanos , Ilhotas Pancreáticas/imunologiaRESUMO
Sixteen nephrotized rats and eight controls were submitted to a continuous sterol balance for two weeks. During the whole experiment (two months) the rats were pair-fed a balanced sterol-free diet and their proteinuria regularly measured as a parameter of the nephrotic state. Serum cholesterol and albumin were also measured at the end of the experiment. Liver and carcass (excluding intestine and central nervous system) as well as feces were submitted to sterol analysis by gas-liquid chromatography. Sterol losses were corrected for by adding radioactive cholesterol and cholic acid at the beginning of the methodological procedures. The results showed that while fecal sterol excretion was similar in the nephrotic group as compared to controls, a definite increase in serum, carcass, and liver cholesterol was observed in the nephrotic animals, indicating that a real enhancement of synthesis had occurred. The meaning of increased cholesterol hepatic content is discussed, as well as the possible relationship between enhanced protein and cholesterol hepatic synthesis.